Biocardia Stock Future Price Prediction

BCDA -  USA Stock  

USD 1.55  0.14  8.28%

Biocardia stock price prediction is an act of determining the future value of Biocardia shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Biocardia's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Biocardia and does not consider all of the tangible or intangible factors available from Biocardia's fundamental data. We analyze noise-free headlines and recent hype associated with Biocardia, which may create opportunities for some arbitrage if properly timed.
Continue to Biocardia Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Biocardia based on different types of headlines from major news networks to social media. The Biocardia stock price prediction module provides an analysis of price elasticity to changes in media outlook on Biocardia over a specific investment horizon. Using Biocardia hype-based prediction, you can estimate the value of Biocardia from the perspective of Biocardia response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Biocardia using Biocardia's options and short interest. It helps to benchmark the overall future attitude of investors towards Biocardia using crowd psychology based on the activity and movement of Biocardia's stock price.
Biocardia Book Value per Share is projected to drop slightly based on the last few years of reporting. The past year's Book Value per Share was at 0.61. The current year Current Ratio is expected to grow to 3.73, whereas Asset Turnover is forecasted to decline to 0.05.

Biocardia Implied Volatility

Biocardia's implied volatility exposes the market's sentiment of Biocardia stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biocardia's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biocardia stock will not fluctuate a lot when Biocardia's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Biocardia. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Biocardia to buy its stock at a price that has no basis in reality. In that case, they are not buying Biocardia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Biocardia after-hype prediction price

  $ 1.49  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Biocardia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Biocardia in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
3 Analysts
LowTarget PriceHigh
Estimates (2)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Biocardia. Your research has to be compared to or analyzed against Biocardia's peers to derive any actionable benefits. When done correctly, Biocardia's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Biocardia.

Biocardia After-Hype Price Prediction Density Analysis

As far as predicting the price of Biocardia at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biocardia or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Biocardia, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Biocardia Estimiated After-Hype Price Volatility

In the context of predicting Biocardia's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biocardia's historical news coverage. Biocardia's after-hype downside and upside margins for the prediction period are 0.07 and 7.01, respectively. We have considered Biocardia's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 1.55
After-hype Price
Biocardia is risky asset. Analysis and calculation of next after-hype price of Biocardia is based on 3 months time horizon.

Biocardia Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Biocardia is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biocardia backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biocardia, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
  0.31  5.60   0.19   0.05  6 Events / Month1 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Biocardia Hype Timeline

Biocardia is currently traded for 1.55. The entity has historical hype elasticity of -0.19 and average elasticity to hype of competition of 0.05. Biocardia is forecasted to decline in value after the next headline with price expected to drop to 1.49. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -8.59% whereas the daily expected return is currently at -0.31%. The volatility of related hype on Biocardia is about 3393.94% with expected price after next announcement by competition of 1.6. About 31.0% of the company shares are held by company insiders. The book value of Biocardia was currently reported as 0.8. The company recorded a loss per share of 0.76. Biocardia had not issued any dividends in recent years. The entity had a split on the 6th of June 2019. Given the investment horizon of 90 days the next forecastedpress releasewill be in about 6 days.
Continue to Biocardia Basic Forecasting Models to cross-verify your projections.

Biocardia Related Hype Analysis

Having access to credible news sources related to Biocardia's direct competition is more important than ever and may enhance your ability to predict Biocardia's future price movements. Getting to know how Biocardia rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biocardia may potentially react to the hype associated with one of its peers.

Biocardia Additional Predictive Modules

Most predictive techniques to examine Biocardia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biocardia using various technical indicators. When you analyze Biocardia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Biocardia Predictive Indicators

The successful prediction of Biocardia stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biocardia, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biocardia based on analysis of Biocardia hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biocardia's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biocardia's related companies.

Story Coverage note for Biocardia

The number of cover stories for Biocardia depends on current market conditions and Biocardia's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biocardia is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biocardia's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Biocardia Short Properties

Biocardia's future price predictability will typically decrease when Biocardia's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biocardia often depends not only on the future outlook of the potential Biocardia's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biocardia's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out3.59%
Short Percent Of Float4.27%
Float Shares10.71M
Shares Short Prior Month499.87k
Average Daily Volume Last 10 Day89.22k
Average Daily Volume In Three Month728.04k
Date Short Interest29th of April 2022
Continue to Biocardia Basic Forecasting Models to cross-verify your projections. Note that the Biocardia information on this page should be used as a complementary analysis to other Biocardia's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Biocardia Stock analysis

When running Biocardia price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Correlations
Find global opportunities by holding instruments from different markets
Is Biocardia's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocardia. If investors know Biocardia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biocardia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biocardia is measured differently than its book value, which is the value of Biocardia that is recorded on the company's balance sheet. Investors also form their own opinion of Biocardia's value that differs from its market value or its book value, called intrinsic value, which is Biocardia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biocardia's market value can be influenced by many factors that don't directly affect Biocardia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biocardia's value and its price as these two are different measures arrived at by different means. Investors typically determine Biocardia value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biocardia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.